Inaba Taro
Founder at Remiges Ventures Inc.
Profile
Inaba Taro is a managing partner and managing director at Remiges Ventures Inc., a company he founded in 2014.
He is also currently a director at Capacity Bio, Inc. In the past, he worked as a general manager at Mitsui & Co., Ltd.
from 2009 to 2014.
Mr. Taro received his undergraduate degree from Kyoto University in 1991 and his MBA from the European University at Saint Petersburg in 1995.
Inaba Taro active positions
Companies | Position | Start |
---|---|---|
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Founder | 2014-05-31 |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Director/Board Member | - |
Former positions of Inaba Taro
Companies | Position | End |
---|---|---|
MITSUI & CO., LTD. | Corporate Officer/Principal | 2014-04-30 |
Training of Inaba Taro
Kyoto University | Undergraduate Degree |
European University at Saint Petersburg | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MITSUI & CO., LTD. | Process Industries |
Private companies | 2 |
---|---|
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Finance |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Health Technology |
- Stock Market
- Insiders
- Inaba Taro